CCA
ABBV icon

Cora Capital Advisors’s AbbVie ABBV Stock Holding History

Cora Capital Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$473K Buy
1,881
+5
+0.3% +$1.08K 0.13% 76
2026
Q1 		$408K Buy
1,876
+208
+12% +$46.1K 0.14% 76
2025
Q4 		$381K Buy
1,668
+225
+16% +$51.3K 0.15% 77
2025
Q3 		$334K Buy
1,443
+204
+16% +$41.5K 0.14% 77
2025
Q2 		$230K Sell
1,239
-46
-4% -$8.55K 0.1% 97
2025
Q1 		$269K Sell
1,285
-37
-3% -$7.19K 0.13% 84
2024
Q4 		$235K Sell
1,322
-89
-6% -$16.4K 0.11% 88
2024
Q3 		$279K Sell
1,411
-26
-2% -$4.85K 0.14% 80
2024
Q2 		$246K Buy
1,437
+11
+0.8% +$1.82K 0.13% 83
2024
Q1 		$260K Buy
1,426
+5
+0.4% +$862 0.14% 80
2023
Q4 		$220K Buy
1,421
+5
+0.4% +$729 0.13% 86
2023
Q3 		$211K Buy
+1,416
New +$208K 0.14% 83
2023
Q2 		– Sell
-1,257
Closed -$200K – 93
2023
Q1 		$200K Buy
+1,257
New +$192K 0.15% 86

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cora Capital Advisors's ABBV Position: Q2 2026 in Review

Cora Capital Advisors increased its AbbVie (ABBV) stake by 0.27% in Q2 2026, buying an estimated $1.08K and bringing the position to 1,881 shares worth $473K. The position accounts for 0.13% of the portfolio, ranked #76.

Cora Capital Advisors first reported a position in ABBV in Q1 2023 and has held it in 13 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Cora Capital Advisors held 1,881 shares of AbbVie worth $473K as of Q2 2026.
  • Cora Capital Advisors bought 5 AbbVie shares in Q2 2026, an estimated $1.08K.
  • AbbVie made up 0.13% of Cora Capital Advisors's portfolio in Q2 2026, its #76 holding.
  • Cora Capital Advisors first reported a position in AbbVie in Q1 2023 and has held it in 13 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Cora Capital Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.